BRINTELLIX Film-coated Tablet
Vortioxetine
20 mg
BIOGEN IDEC B.V.
| Pack size | 28's Pack |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price | 8.37 AED |
Available as:
Indications
BRINTELLIX Film-coated Tablet is used for:
Vortioxetine is indicated for the treatment of major depressive disorder (MDD).
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Vortioxetine :
Mechanism of Action
Vortioxetine is classified as a serotonin modulator and simulator (SMS) as it has a multimodal mechanism of action towards the serotonin neurotransmitter system whereby it simultaneously modulates one or more serotonin receptors and inhibits the reuptake of serotonin. More specifically, vortioxetine acts via the following biological mechanisms: as a serotonin reuptake inhibitor (SRI) through inhibition of the serotonin transporter, while also acting as a partial agonist of the 5-HT1B receptor, an agonist of 5-HT1A, and antagonist of the 5-HT3, 5-HT1D, and 5-HT7 receptors.
Note
BRINTELLIX 20 mg Film-coated Tablet manufactured by BIOGEN IDEC B.V.. Its generic name is Vortioxetine. BRINTELLIX is availble in Saudi Arabia.
Farmaco SA drug index information on BRINTELLIX Film-coated Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.